Home
Issues
2022
May 2022 - Vol 15 No 3
March 2022 - Vol 15 No 2
January 2022 - Vol 15 No 1 – Online Only
2021
November 2021 - Vol 14 No 7
October 2021 - Vol 14 No 6 | Biosimilars
September 2021 - Vol 14 No 5
July 2021 - Vol 14 No 4
May 2021 - Vol 14 No 3
March 2021 - Vol 14 No 2
January 2021 - Vol 14 No 1
2020
November 2020, Vol 13, No 6
September 2020 - Vol 13 no 5
July 2020 - Vol 13 no 4
May 2020 - Vol 13 no 3
March 2020 - Vol 13 no 2
January 2020 - Vol 13 No 1
2019
November 2019 - Vol 12 No 4
August 2019 - Vol 12 No 3
May 2019 - Vol 12 No 2
February 2019 - Vol 12 No 1
Issue Archive
Special Issues
Supplements
ASK THE EXPERT: First-Line Treatment of Metastatic Non-small cell Lung Cancer
Checkmate 9LA
Checkmate 227
Guide to New FDA Approvals
2019 Fourth Annual Guide
2018 Third Annual Guide
2017 Second Annual Guide
2016 First Annual Guide
Categories
Conference Correspondent
ASCO 2021 Wrap-Up - Breast Cancer
Web Exclusives
Ovarian Cancer Overview
Interview with the Innovators
All Web Exclusives
Drug Updates
FDA Approvals, News & Updates
In the News
Press Releases
Online First
Media Library
Videos
Audiocasts
Quick Quiz
CE
About
About TOP
Advertise
Editorial Board
Contact Us
Resources
Submit
Author Guidelines
Audrey Andrews
Authored Items
Suboptimal Dosing of Filgrastim Is Acceptable for Treatment of Chemotherapy-Induced Neutropenia
Audrey Andrews
TOP - August 2018, Vol 11, No 2
in
Side-Effects Management
Project Aims to Prevent Future Infusion-Related Reactions
Audrey Andrews
TOP - May 2017, Vol 10, No 2
in
NCCN News
,
NCCN
Noncompliance with Granulocyte Colony-Stimulating Factor Guidelines Has Consequences
Audrey Andrews
TOP - May 2017, Vol 10, No 2
in
NCCN News
,
NCCN
Pharmacy-Led Intervention Improved Tyrosine Kinase Inhibitor Adherence and Monitoring
Audrey Andrews
TOP - May 2017, Vol 10, No 2
in
NCCN News
,
NCCN
New Survey Reveals How Pharmacies Manage Verification Processes
Audrey Andrews
TOP - November 2016, Vol 9, No 4
in
Best Practices
Dose Modifications of Lenalidomide Lead to Good Outcomes in Myelodysplastic Syndrome
Audrey Andrews
TOP - November 2016, Vol 9, No 4
in
Hematologic Cancers
Managing Dermatologic Toxicities
Audrey Andrews
TOP November 2015 Vol 8 No 4
in
Conference Correspondent
Managing Dermatologic Toxicities
Audrey Andrews
Web Exclusives
in
Conference Correspondent
Peripheral Arterial Disease Seen With Nilotinib
Audrey Andrews
TOP - February 2013 VOL 6, NO 1
in
Supportive Care
Crizotinib Is Just the Beginning
Audrey Andrews
TOP - December 2012 VOL 5, NO 8
Exemestane: A Promising New Option for Primary Prevention of Breast Cancer
Audrey Andrews
Online First
in
Conference Correspondent
Bevacizumab in Ovarian Cancer: More Support for Maintenance
Audrey Andrews
Online First
in
Conference Correspondent
Novel Agents Improve Survival in Metastatic Melanoma
Audrey Andrews
Online First
in
Conference Correspondent
PARP Inhibitor Prolongs Progression-Free Survival in Ovarian Cancer
Audrey Andrews
Online First
in
Conference Correspondent
NCCN Helps Guide Optimal Use of Myeloid Growth Factors for Prevention of Neutropenia
Audrey Andrews
Online First
in
Supportive Care
Last modified: December 11, 2015
Home
Issues
2022
May 2022 - Vol 15 No 3
March 2022 - Vol 15 No 2
January 2022 - Vol 15 No 1 – Online Only
2021
November 2021 - Vol 14 No 7
October 2021 - Vol 14 No 6 | Biosimilars
September 2021 - Vol 14 No 5
July 2021 - Vol 14 No 4
May 2021 - Vol 14 No 3
March 2021 - Vol 14 No 2
January 2021 - Vol 14 No 1
2020
November 2020, Vol 13, No 6
September 2020 - Vol 13 no 5
July 2020 - Vol 13 no 4
May 2020 - Vol 13 no 3
March 2020 - Vol 13 no 2
January 2020 - Vol 13 No 1
2019
November 2019 - Vol 12 No 4
August 2019 - Vol 12 No 3
May 2019 - Vol 12 No 2
February 2019 - Vol 12 No 1
Issue Archive
Special Issues
Supplements
ASK THE EXPERT: First-Line Treatment of Metastatic Non-small cell Lung Cancer
Checkmate 9LA
Checkmate 227
Guide to New FDA Approvals
2019 Fourth Annual Guide
2018 Third Annual Guide
2017 Second Annual Guide
2016 First Annual Guide
Categories
Conference Correspondent
ASCO 2021 Wrap-Up - Breast Cancer
Web Exclusives
Ovarian Cancer Overview
Interview with the Innovators
All Web Exclusives
Drug Updates
FDA Approvals, News & Updates
In the News
Press Releases
Online First
Media Library
Videos
Audiocasts
Quick Quiz
CE
About
About TOP
Advertise
Editorial Board
Contact Us
Resources
Submit
Author Guidelines
Sign Up Now!
To sign up for our newsletter or print publications, please enter your contact information below and click "Subscribe".
First Name
*
Last Name
*
Email Address
*
Email Address (Verify)
*
TOP
Print Edition
We will request your mailing address on the next page.
TOP
E-Newsletters and Communications
JHOP
Print Edition
We will request your mailing address on the next page.
JHOP
E-Newsletters and Communications
I have reviewed and consent to the terms of
TOP
's
Privacy Policy
, and
TOP
has my permission to retain my information in its database, and to forward pertinent communications to me.